ConductScience.org, home

Paper33436624

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir.

Kokic G and 9 others. Nat Commun, 2021. Cited by 473 papers, by iCite.

Cite this record

ConductScience Library. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Papers, record 33436624. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33436624

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir.
PubMed
Journal
Nat Commun
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
473
iCite
Relative citation ratio, by iCite
28.7
iCite
Revised in PubMed
2024-08-05
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kokic GGoranhttps://orcid.org/0000-0001-8912-7099
2Hillen HSHauke Shttps://orcid.org/0000-0002-1206-0129
3Tegunov DDimitryhttps://orcid.org/0000-0001-7019-3221
4Dienemann CChristian
5Seitz FFlorian
6Schmitzova JJana
7Farnung LLucashttps://orcid.org/0000-0002-8200-2493
8Siewert AAaron
9Höbartner CClaudiahttps://orcid.org/0000-0002-4548-2299
10Cramer PPatrickhttps://orcid.org/0000-0001-5454-7755

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenosine MonophosphateMajor topic
AlanineMajor topic
RNA-Dependent RNA PolymeraseMajor topic
SARS-CoV-2Major topic
Antiviral Agents
Aptamers, Nucleotide
Coronavirus RNA-Dependent RNA Polymerase
Nucleotides
RNA, Viral
Virus Replication
COVID-19 Drug Treatment

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129067766MolProbity: More and better reference data for improved all-atom structure validation.Protein Sci2018https://conductscience.org/library/papers/29067766PubMed
233264556Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.N Engl J Med2021https://conductscience.org/library/papers/33264556PubMed
332020029Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.Cell Res2020https://conductscience.org/library/papers/32020029PubMed
432853546Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.Mol Cell2020https://conductscience.org/library/papers/32853546PubMed
519426741Binding of 2'-amino-2'-deoxycytidine-5'-triphosphate to norovirus polymerase induces rearrangement of the active site.J Mol Biol2009https://conductscience.org/library/papers/19426741PubMed
632881101UCSF ChimeraX: Structure visualization for researchers, educators, and developers.Protein Sci2021https://conductscience.org/library/papers/32881101PubMed
729511076Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.mBio2018https://conductscience.org/library/papers/29511076PubMed
824269475SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets.Antiviral Res2014https://conductscience.org/library/papers/24269475PubMed
924012996From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses.Antiviral Res2013https://conductscience.org/library/papers/24012996PubMed
1032358203Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.Science2020https://conductscience.org/library/papers/32358203PubMed
1128174054Nidovirus RNA polymerases: Complex enzymes handling exceptional RNA genomes.Virus Res2017https://conductscience.org/library/papers/28174054PubMed
1228165473cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination.Nat Methods2017https://conductscience.org/library/papers/28165473PubMed
1328659436Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.Sci Transl Med2017https://conductscience.org/library/papers/28659436PubMed
1432649078Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.N Engl J Med2020https://conductscience.org/library/papers/32649078PubMed
1532438371Structure of replicating SARS-CoV-2 polymerase.Nature2020https://conductscience.org/library/papers/32438371PubMed
1622791111Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates.Arch Virol2012https://conductscience.org/library/papers/22791111PubMed
1719770504electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation.Acta Crystallogr D Biol Crystallogr2009https://conductscience.org/library/papers/19770504PubMed
1832849448Directly Acting Antivirals for COVID-19: Where Do We Stand?Front Microbiol2020https://conductscience.org/library/papers/32849448PubMed
1928124907Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.J Med Chem2017https://conductscience.org/library/papers/28124907PubMed
2029872004Real-space refinement in PHENIX for cryo-EM and crystallography.Acta Crystallogr D Struct Biol2018https://conductscience.org/library/papers/29872004PubMed

See all 40 referencesDownload CSV of references

Cited by349

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 473 citations.

PMIDTitleJournalYearIn PapersSource
42959435Virology-aware artificial intelligence for respiratory antiviral discovery: from molecular docking biases to RdRp-centered benchmarking.Front Pharmacol2026https://conductscience.org/library/papers/42959435PubMed
42921893An Oral Antiviral Combination Against Severe COVID-19 Enabled by the Synergistic Mechanisms of Action of Auranofin and Remdesivir.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42921893PubMed
42895065Highly effective viral RdRP translocation hindrance by the remdesivir nucleotide.Nucleic Acids Res2026https://conductscience.org/library/papers/42895065PubMed
42891015An open-label feasibility study of remdesivir in long COVID: results from the ERASE LC trial.Oxf Open Immunol2026https://conductscience.org/library/papers/42891015PubMed
42859170An efficient and versatile reverse genetics system for bovine coronavirus facilitates antiviral evaluation.Vet Res2026https://conductscience.org/library/papers/42859170PubMed
42755944Remdesivir nephrotoxicity in tubular epithelial cells.Front Pharmacol2026https://conductscience.org/library/papers/42755944PubMed
42655729Molecular Insights into High-Pathogenicity RNA Viruses.Viruses2026https://conductscience.org/library/papers/42655729PubMed
42626842Coronavirus NSP14 drives internal m7G modification to rewire host splicing and promote viral replication.Nucleic Acids Res2026https://conductscience.org/library/papers/42626842PubMed
42482992Dynamic regulatory mechanism of cholesterol 25-hydroxylase-mediated antiviral response in RNA virus infections.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42482992PubMed
42439623Combination of Remdesivir and Ivermectin Exerts Highly Potent and Synergistic Antiviral Activity Against Murine Coronavirus and SARS-CoV-2 Infections.Cells2026https://conductscience.org/library/papers/42439623PubMed
42412629Recent advances in functional studies of coronavirus NSP13 helicase and challenges in inhibitor development.Virulence2026https://conductscience.org/library/papers/42412629PubMed
42409264Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.J Biol Chem2026https://conductscience.org/library/papers/42409264PubMed
42319933Copy-back RNA synthesis by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravir.Sci Adv2026https://conductscience.org/library/papers/42319933PubMed
42245809RNA with Azvudine Incorporated One Nucleotide Upstream of 3'-End Resists Cleavage by SARS-CoV-2 Proofreading Exonuclease.Res Sq2026https://conductscience.org/library/papers/42245809PubMed
42138434
Host-directed antiviral strategy targeting prohibitins: Mel56 suppresses influenza A virus and severe acute respiratory syndrome coronavirus 2 via modulation of antioxidant pathways and mitochondrial function.
Microbiol Spectr2026https://conductscience.org/library/papers/42138434PubMed
41999602RNA virus polymerase-helicase coupling enables rapid elongation through duplex RNA.Cell Rep2026https://conductscience.org/library/papers/41999602PubMed
41855156SAMHD1 depletion restricts SARS-CoV-2 infection by suppressing HNF1-dependent ACE2 expression in lung epithelial cells.PLoS Pathog2026https://conductscience.org/library/papers/41855156PubMed
41826755Preferential remdesivir triphosphate incorporation by SARS-CoV-2 polymerase is altered to ATP by the S759A mutation.Commun Biol2026https://conductscience.org/library/papers/41826755PubMed
41769697Remdesivir in COVID-19: pros and cons.Front Pharmacol2026https://conductscience.org/library/papers/41769697PubMed
41764271Pyrogallol B-ring enhances catechin binding to the SARS-CoV-2 spike receptor-binding domain to inhibit interaction with ACE2.Sci Rep2026https://conductscience.org/library/papers/41764271PubMed

See all 349 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CAPZB832PubTator's text mininghttps://conductscience.org/library/genes/832

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33436624

GET https://conductscience.org/api/papers/v1/33436624/references?page=2